101 – 135 of 135
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2005
-
Mark
Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales
(
- Contribution to journal › Letter
-
Mark
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
(
- Contribution to journal › Article
-
Mark
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
Response criteria for rheumatoid arthritis in clinical practice - how useful are they?
(
- Contribution to journal › Article
- 2004
-
Mark
Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al
(
- Contribution to journal › Letter
-
Mark
TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden.
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept.
(
- Contribution to journal › Article
- 2002
-
Mark
Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.
(
- Contribution to journal › Article
- 2001
-
Mark
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
(
- Contribution to journal › Article
-
Mark
Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis
(
- Contribution to journal › Article
- 2000
-
Mark
Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis
(
- Contribution to journal › Article
- 1997
-
Mark
Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction
(
- Contribution to journal › Article
- 1995
-
Mark
Hip involvement in early rheumatoid arthritis
(
- Contribution to journal › Article
- 1994
-
Mark
Prevention of joint destruction in antigen-induced arthritis
(
- Contribution to journal › Article
- 1993
-
Mark
Antiproliferative effects on human peripheral blood mononuclear cells and inhibition of in vitro immunoglobulin synthesis by Podophyllotoxin (CPH86) and by semisynthetic lignan glycosides (CPH82)
(
- Contribution to journal › Article
-
Mark
Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis
(
- Contribution to journal › Article
- 1992
-
Mark
Cytidine deaminase and lactoferrin in inflammatory synovial fluids. Indicators of local polymorphonuclear cell function?
(
- Contribution to journal › Article
- 1991
-
Mark
Septic arthritis as a non-surgical complication in rheumatoid arthritis: relation to disease severity and therapy
(
- Contribution to journal › Article
- 1990
-
Mark
MR imaging of the knee in acute rheumatoid arthritis: synovial uptake of gadolinium-DOTA
1990) In American Journal of Roentgenology: diagnostic imaging and related sciences 155(2). p.329-332(
- Contribution to journal › Article
-
Mark
IgM-ANCA in a patient with systemic vasculitis without pulmonary involvement
(
- Contribution to journal › Article
-
Mark
Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release
(
- Contribution to journal › Article
-
Mark
Intraarticular corticosteroid injection into rheumatoid arthritis knees improves extensor muscles strength
(
- Contribution to journal › Article
- 1989
-
Mark
Joint capsular stiffness in knee arthritis. Relationship to intraarticular volume, hydrostatic pressures, and extensor muscle function
(
- Contribution to journal › Article
-
Mark
Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints
(
- Contribution to journal › Article
-
Mark
Direct assessment of synovial blood flow and its relation to induced hydrostatic pressure changes
(
- Contribution to journal › Article
- 1988
-
Mark
Individually adapted lightweight walking aids with moulded handles for patients with severely deforming chronic arthritis
(
- Contribution to journal › Article
-
Mark
Measurement of synovial fluid volume using albumin dilution upon intraarticular saline injection
(
- Contribution to journal › Article
-
Mark
Inhibition of ConA-induced proliferative response in human lymphocytes by podophyllotoxin and a detergent, Tween80
(
- Contribution to journal › Article
-
Mark
Measurement of oxygen and carbon dioxide partial pressures in synovial fluid after tonometry
(
- Contribution to journal › Article
-
Mark
Mononuclear cells recovered from inflammatory synovial membrane using fine-needle biopsy
(
- Contribution to journal › Article
- 1987
-
Mark
Hyaluronidase treatment of synovial fluid affects the recovery of mononuclear cells and their in vitro immunoglobulin synthesis
(
- Contribution to journal › Article
- 1984
-
Mark
Acute alveolitis and sulphasalazine in rheumatoid arthritis
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »